Biosimilars Price Controls

United Kingdom Proposes Applying Price Controls to Biosimilars


The government has launched a consultation that outlines the proposed changes to its price controls, which require brand-name drug makers to pay the government 7.8% of their sales of products to the National Health Service.

Read the full article by Kelly Davio here.

Colorful capsules on British Pound notes. Isolated on white.

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.